Evidence Based Social Science Research Centre, School of Public Health, Lanzhou University, Lanzhou, China.
Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, China.
BMJ. 2020 Apr 1;369:m696. doi: 10.1136/bmj.m696.
To determine the relative effectiveness of dietary macronutrient patterns and popular named diet programmes for weight loss and cardiovascular risk factor improvement among adults who are overweight or obese.
Systematic review and network meta-analysis of randomised trials.
Medline, Embase, CINAHL, AMED, and CENTRAL from database inception until September 2018, reference lists of eligible trials, and related reviews.
Randomised trials that enrolled adults (≥18 years) who were overweight (body mass index 25-29) or obese (≥30) to a popular named diet or an alternative diet.
Change in body weight, low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, systolic blood pressure, diastolic blood pressure, and C reactive protein at the six and 12 month follow-up.
Two reviewers independently extracted data on study participants, interventions, and outcomes and assessed risk of bias, and the certainty of evidence using the GRADE (grading of recommendations, assessment, development, and evaluation) approach. A bayesian framework informed a series of random effects network meta-analyses to estimate the relative effectiveness of the diets.
121 eligible trials with 21 942 patients were included and reported on 14 named diets and three control diets. Compared with usual diet, low carbohydrate and low fat diets had a similar effect at six months on weight loss (4.63 4.37 kg, both moderate certainty) and reduction in systolic blood pressure (5.14 mm Hg, moderate certainty 5.05 mm Hg, low certainty) and diastolic blood pressure (3.21 2.85 mm Hg, both low certainty). Moderate macronutrient diets resulted in slightly less weight loss and blood pressure reductions. Low carbohydrate diets had less effect than low fat diets and moderate macronutrient diets on reduction in LDL cholesterol (1.01 mg/dL, low certainty 7.08 mg/dL, moderate certainty 5.22 mg/dL, moderate certainty, respectively) but an increase in HDL cholesterol (2.31 mg/dL, low certainty), whereas low fat (-1.88 mg/dL, moderate certainty) and moderate macronutrient (-0.89 mg/dL, moderate certainty) did not. Among popular named diets, those with the largest effect on weight reduction and blood pressure in comparison with usual diet were Atkins (weight 5.5 kg, systolic blood pressure 5.1 mm Hg, diastolic blood pressure 3.3 mm Hg), DASH (3.6 kg, 4.7 mm Hg, 2.9 mm Hg, respectively), and Zone (4.1 kg, 3.5 mm Hg, 2.3 mm Hg, respectively) at six months (all moderate certainty). No diets significantly improved levels of HDL cholesterol or C reactive protein at six months. Overall, weight loss diminished at 12 months among all macronutrient patterns and popular named diets, while the benefits for cardiovascular risk factors of all interventions, except the Mediterranean diet, essentially disappeared.
Moderate certainty evidence shows that most macronutrient diets, over six months, result in modest weight loss and substantial improvements in cardiovascular risk factors, particularly blood pressure. At 12 months the effects on weight reduction and improvements in cardiovascular risk factors largely disappear.
PROSPERO CRD42015027929.
确定在超重或肥胖的成年人中,宏量营养素模式和流行的命名饮食计划对减肥和心血管风险因素改善的相对有效性。
随机试验的系统评价和网络荟萃分析。
从数据库建立到 2018 年 9 月,在 Medline、Embase、CINAHL、AMED 和 CENTRAL 中搜索随机试验,查阅合格试验的参考文献列表和相关综述。
招募超重(体重指数 25-29)或肥胖(≥30)成年人(≥18 岁)参加流行命名饮食或替代饮食的随机试验。
在 6 个月和 12 个月的随访中,体重、低密度脂蛋白(LDL)胆固醇、高密度脂蛋白(HDL)胆固醇、收缩压、舒张压和 C 反应蛋白的变化。
两名审查员独立提取研究参与者、干预措施和结局的数据,并使用 GRADE(推荐分级、评估、开发和评估)方法评估风险偏倚和证据的确定性。贝叶斯框架为一系列随机效应网络荟萃分析提供了信息,以估计饮食的相对有效性。
纳入了 121 项合格试验,涉及 21942 名患者,报告了 14 种命名饮食和 3 种对照饮食。与常规饮食相比,低碳水化合物和低脂肪饮食在 6 个月时对体重减轻(4.634.37kg,均为中度确定性)和收缩压(5.14mm Hg,中度确定性 5.05mm Hg,低确定性)和舒张压(3.212.85mm Hg,均为低确定性)的降低具有相似的效果。中等宏量营养素饮食导致体重减轻和血压降低的效果略低。低碳水化合物饮食在降低 LDL 胆固醇方面的效果不如低脂肪饮食和中等宏量营养素饮食(1.01mg/dL,低确定性 7.08mg/dL,中度确定性 5.22mg/dL,中度确定性),但 HDL 胆固醇(2.31mg/dL,低确定性)升高,而低脂肪饮食(-1.88mg/dL,中度确定性)和中等宏量营养素饮食(-0.89mg/dL,中度确定性)则没有。在流行的命名饮食中,与常规饮食相比,对体重减轻和血压影响最大的是阿特金斯(体重减轻 5.5kg,收缩压降低 5.1mm Hg,舒张压降低 3.3mm Hg)、DASH(3.6kg,4.7mm Hg,2.9mm Hg,分别)和区域(4.1kg,3.5mm Hg,2.3mm Hg,分别),在 6 个月时(均为中度确定性)。没有饮食在 6 个月时显著改善 HDL 胆固醇或 C 反应蛋白水平。总体而言,所有宏量营养素模式和流行的命名饮食在 12 个月时的体重减轻效果均减弱,而除地中海饮食外,所有干预措施对心血管风险因素的益处基本上都消失了。
中等确定性证据表明,大多数宏量营养素饮食在 6 个月内可适度减轻体重,并显著改善心血管风险因素,尤其是血压。在 12 个月时,减轻体重和改善心血管风险因素的效果大部分消失。
PROSPERO CRD42015027929。